These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27287676)

  • 1. Patient-Centered Outcome Measures in Lung Cancer Trials.
    Schulkes KJ; Nguyen C; van den Bos F; Hamaker ME; van Elden LJ
    Lung; 2016 Aug; 194(4):647-52. PubMed ID: 27287676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?
    Hamaker ME; Stauder R; van Munster BC
    Ann Oncol; 2014 Mar; 25(3):675-681. PubMed ID: 24458474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
    Schulkes KJ; Nguyen C; van den Bos F; van Elden LJ; Hamaker ME
    Lung; 2016 Dec; 194(6):967-974. PubMed ID: 27650509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries.
    Riedl D; Rothmund M; Darlington AS; Sodergren S; Crazzolara R; de Rojas T;
    Eur J Cancer; 2021 Jul; 152():90-99. PubMed ID: 34090144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review.
    Bouazza YB; Chiairi I; El Kharbouchi O; De Backer L; Vanhoutte G; Janssens A; Van Meerbeeck JP
    Lung Cancer; 2017 Nov; 113():140-151. PubMed ID: 29110842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
    Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current palliative chemotherapy trials in the elderly neglect patient-centred outcome measures.
    van Bekkum ML; van Munster BC; Thunnissen PL; Smorenburg CH; Hamaker ME
    J Geriatr Oncol; 2015 Jan; 6(1):15-22. PubMed ID: 25287966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endpoints in cancer clinical trials.
    Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
    J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.
    Hamaker ME; Stauder R; van Munster BC
    Oncologist; 2014 Oct; 19(10):1069-75. PubMed ID: 25170014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based approach to compare patient-reported outcomes of long-term Hodgkin's lymphoma survivors according to trial participation: a joint study from the Patient-Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship registry and European Organisation for Research and Treatment of Cancer.
    Thong MSY; Kicinski M; Coens C; Giusti F; van de Poll-Franse L; Bogaerts J; Liu L
    Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S223-S228. PubMed ID: 28574866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing relevant endpoints for older breast cancer patients in clinical trials: an overview of all current clinical trials on breast cancer treatment.
    de Glas NA; Hamaker ME; Kiderlen M; de Craen AJ; Mooijaart SP; van de Velde CJ; van Munster BC; Portielje JE; Liefers GJ; Bastiaannet E
    Breast Cancer Res Treat; 2014 Aug; 146(3):591-7. PubMed ID: 25005573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).
    Mercieca-Bebber R; Williams D; Tait MA; Roydhouse J; Busija L; Sundaram CS; Wilson M; Langford A; Rutherford C; Roberts N; King M; Vodicka E; Devine B;
    Qual Life Res; 2018 Oct; 27(10):2581-2591. PubMed ID: 29915979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms.
    Kluetz PG; Slagle A; Papadopoulos EJ; Johnson LL; Donoghue M; Kwitkowski VE; Chen WH; Sridhara R; Farrell AT; Keegan P; Kim G; Pazdur R
    Clin Cancer Res; 2016 Apr; 22(7):1553-8. PubMed ID: 26758559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual point-of-care trials: a new approach to incorporate patient's preferences into personalized pragmatic clinical trials.
    Sacristán JA; Knottnerus JA
    J Clin Epidemiol; 2021 Feb; 130():152-155. PubMed ID: 33002636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and reporting of patient-reported outcomes in phase III breast cancer trials.
    Brim RL; Pearson SD
    Clin Trials; 2013 Apr; 10(2):243-9. PubMed ID: 23539108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.
    Subramanian J; Madadi AR; Dandona M; Williams K; Morgensztern D; Govindan R
    J Thorac Oncol; 2010 Aug; 5(8):1116-9. PubMed ID: 20592626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.